Formulation, characterization and permeability study of nano particles of lipo-endomorphin-1 for oral delivery

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of liposome research

• Publication date

  2013-10-08

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.3109/08982104.2013.805339PMID 23931529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Converging toward a common speech code: imitative and perceptuo-motor recalibration processes in speech production

  2013cited by this paper
• Synthesis and biological evaluation of an orally active glycosylated endomorphin-1.

  2012cited by this paper
• Lipo-Endomorphin-1 Derivatives with Systemic Activity against Neuropathic Pain without Producing Constipation

  2012cited by this paper
• Salmon calcitonin-loaded Eudragit® and Eudragit®-PLGA nanoparticles: in vitro and in vivo evaluation

  2012cited by this paper
• An investigation into liposomal formulations for targeted drug delivery to the colon

  2012cited by this paper
• Mucoadhesive liposomal delivery systems: the choice of coating material

  2011influential reference
• Pharmacology of a new tritiated endomorphin-2 analog containing the proline mimetic cis-2-aminocyclohexanecarboxylic acid.

  2011cited by this paper
• Development of enteric submicron particle formulation of papain for oral delivery

  2011cited by this paper
• The oral delivery of proteins using interpolymer polyelectrolyte complexes.

  2011cited by this paper
• pH-sensitive Eudragit nanoparticles for mucosal drug delivery.

  2011cited by this paper
• Design, synthesis and pharmacological characterization of endomorphin analogues with non-cyclic amino acid residues in position 2.

  2010cited by this paper
• Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.

  2010cited by this paper
• Evaluation of liposomes coated with a pH responsive polymer.

  2010influential reference
• Recent trends in protein and peptide drug delivery systems

  2009cited by this paper
• Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design

  2009cited by this paper
• The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione.

  2009cited by this paper
• Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System

  2009cited by this paper
• Protein and Peptide Drug Delivery: Oral Approaches

  2008cited by this paper
• Tricalcium phosphate delayed release formulation for oral delivery of insulin: a proof-of-concept study.

  2008cited by this paper
• Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides.

  2008cited by this paper
• Engineering an endomorphin‐2 gene for use in neuropathic pain therapy

  2007cited by this paper
• Solubility of sparingly-soluble ionizable drugs.

  2007cited by this paper
• Solvent systems and their selection in pharmaceutics and biopharmaceutics

  2007cited by this paper
• Influence of selected formulation variables on the preparation of enzyme-entrapped eudragit S100 microspheres

  2007cited by this paper
• Biorelevant Dissolution Media

  2007cited by this paper
• Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.

  2006cited by this paper
• Approaches to oral drug delivery for challenging molecules.

  2006cited by this paper
• Facilitated diffusion in the dissolution of carboxylic polymers

  2005cited by this paper
• Eudragit S100 entrapped insulin microspheres for oral delivery

  2005cited by this paper
• Polymeric Particulates to Improve Oral Bioavailability of Peptide Drugs

  2005cited by this paper
• Oral delivery of peptide drugs: barriers and developments.

  2005cited by this paper
• Adjuvant Effects of Niosome and Water/Oil/Water Multiple Emulsion Carrier Systems for Recombinant Hepatitis B Surface Antigen

  2004cited by this paper
• Nanosuspensions: a promising drug delivery strategy

  2004cited by this paper
• Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation.

  2004cited by this paper
• Solvent injection as a new approach for manufacturing lipid nanoparticles--evaluation of the method and process parameters.

  2003cited by this paper
• In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers.

  2003cited by this paper
• Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats.

  2003cited by this paper
• Emerging trends in oral delivery of peptide and protein drugs.

  2003cited by this paper
• Enzymatic Degradation of Dynasan 114 SLN – Effect of Surfactants and Particle Size

  2002cited by this paper
• Endomorphin analogues containing D‐Pro2 discriminate different μ‐opioid receptor mediated antinociception in mice

  2002cited by this paper
• Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions

  2002cited by this paper
• Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization.

  2002cited by this paper
• In vitro quantitative study of the degradation of endomorphins.

  2002influential reference
• Opioids in chronic pain.

  2001cited by this paper
• Solid lipid nanoparticles: production, characterization and applications.

  2001cited by this paper
• Peroral route: an opportunity for protein and peptide drug delivery.

  2001cited by this paper
• Preparation and evaluation of ketoprofen floating oral delivery system.

  2001cited by this paper
• Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine.

  2000cited by this paper
• Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

  2000influential reference
• Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide.

  2000cited by this paper
• Colloidal carriers for benzathine penicillin G: nanoemulsions and nanocapsules.

  2000cited by this paper
• Kinetic behavior of the pancreatic lipase-colipase-lipid system.

  2000cited by this paper
• Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro‐in vivo evaluation

  2000influential reference
• Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin.

  1999cited by this paper
• Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.

  1998cited by this paper
• Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics.

  1998cited by this paper
• Use of (meth)acrylic acid copolymers to increase the permeability of mucous membranes

  1997cited by this paper
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  1995cited by this paper
• A novel chemical approach to drug delivery: lipidic amino acid conjugates.

  1994cited by this paper

• Recent advances in pain management based on nanoparticle technologies

  2022cites this paper
• Oxytocin Dynamics in the Body and Brain Regulated by the Receptor for Advanced Glycation End-Products, CD38, CD157, and Nicotinamide Riboside

  2022cites this paper
• Enteric-Coated Strategies in Colorectal Cancer Nanoparticle Drug Delivery System

  2020cites this paper
• DDDT_A_273612 4387..4405

  2020cites this paper
• Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs

  2018cites this paper
• Opioid-based micro and nanoparticulate formulations: alternative approach on pain management

  2016cites this paper
• Characterization of particulate drug delivery systems for oral delivery of Peptide and protein drugs.

  2015cites this paper
• Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs.

  2015cites this paper